vs

Side-by-side financial comparison of Analog Devices (ADI) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.2B, roughly 1.4× Analog Devices). Analog Devices runs the higher net margin — 26.3% vs 13.9%, a 12.4% gap on every dollar of revenue. On growth, Analog Devices posted the faster year-over-year revenue change (30.4% vs 4.1%). Analog Devices produced more free cash flow last quarter ($1.3B vs $602.0M). Over the past eight quarters, Analog Devices's revenue compounded faster (21.0% CAGR vs -0.3%).

Analog Devices, Inc. (ADI), also known simply as Analog, is an American multinational semiconductor company specializing in data conversion, signal processing, and power management technology, headquartered in Wilmington, Massachusetts.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

ADI vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.4× larger
EMR
$4.3B
$3.2B
ADI
Growing faster (revenue YoY)
ADI
ADI
+26.3% gap
ADI
30.4%
4.1%
EMR
Higher net margin
ADI
ADI
12.4% more per $
ADI
26.3%
13.9%
EMR
More free cash flow
ADI
ADI
$657.2M more FCF
ADI
$1.3B
$602.0M
EMR
Faster 2-yr revenue CAGR
ADI
ADI
Annualised
ADI
21.0%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ADI
ADI
EMR
EMR
Revenue
$3.2B
$4.3B
Net Profit
$830.8M
$605.0M
Gross Margin
64.7%
53.2%
Operating Margin
31.5%
17.8%
Net Margin
26.3%
13.9%
Revenue YoY
30.4%
4.1%
Net Profit YoY
112.3%
3.4%
EPS (diluted)
$1.69
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADI
ADI
EMR
EMR
Q1 26
$3.2B
Q4 25
$3.1B
$4.3B
Q3 25
$2.9B
$4.9B
Q2 25
$2.6B
$4.6B
Q1 25
$2.4B
$4.4B
Q4 24
$2.4B
$4.2B
Q3 24
$2.3B
$4.6B
Q2 24
$2.2B
$4.4B
Net Profit
ADI
ADI
EMR
EMR
Q1 26
$830.8M
Q4 25
$787.7M
$605.0M
Q3 25
$518.5M
$637.0M
Q2 25
$569.8M
$586.0M
Q1 25
$391.3M
$485.0M
Q4 24
$478.1M
$585.0M
Q3 24
$392.2M
$996.0M
Q2 24
$302.2M
$329.0M
Gross Margin
ADI
ADI
EMR
EMR
Q1 26
64.7%
Q4 25
63.1%
53.2%
Q3 25
62.1%
51.9%
Q2 25
61.0%
52.6%
Q1 25
59.0%
53.5%
Q4 24
58.0%
53.5%
Q3 24
56.7%
51.3%
Q2 24
54.7%
52.8%
Operating Margin
ADI
ADI
EMR
EMR
Q1 26
31.5%
Q4 25
30.7%
17.8%
Q3 25
28.4%
16.4%
Q2 25
25.7%
16.1%
Q1 25
20.3%
14.2%
Q4 24
23.3%
18.6%
Q3 24
21.2%
14.7%
Q2 24
17.9%
10.4%
Net Margin
ADI
ADI
EMR
EMR
Q1 26
26.3%
Q4 25
25.6%
13.9%
Q3 25
18.0%
13.1%
Q2 25
21.6%
12.9%
Q1 25
16.1%
10.9%
Q4 24
19.6%
14.0%
Q3 24
17.0%
21.6%
Q2 24
14.0%
7.5%
EPS (diluted)
ADI
ADI
EMR
EMR
Q1 26
$1.69
Q4 25
$1.60
$1.07
Q3 25
$1.04
$1.12
Q2 25
$1.14
$1.04
Q1 25
$0.78
$0.86
Q4 24
$0.95
$1.02
Q3 24
$0.79
$1.74
Q2 24
$0.61
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADI
ADI
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$2.9B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$33.8B
$20.3B
Total Assets
$48.0B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADI
ADI
EMR
EMR
Q1 26
$2.9B
Q4 25
$3.7B
Q3 25
$2.3B
Q2 25
$2.4B
Q1 25
$2.3B
Q4 24
$2.4B
Q3 24
$2.1B
Q2 24
$2.4B
Total Debt
ADI
ADI
EMR
EMR
Q1 26
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Stockholders' Equity
ADI
ADI
EMR
EMR
Q1 26
$33.8B
Q4 25
$33.8B
$20.3B
Q3 25
$34.1B
$20.3B
Q2 25
$35.0B
$19.9B
Q1 25
$35.1B
$19.2B
Q4 24
$35.2B
$20.5B
Q3 24
$35.2B
$21.6B
Q2 24
$35.2B
$20.8B
Total Assets
ADI
ADI
EMR
EMR
Q1 26
$48.0B
Q4 25
$48.0B
$41.9B
Q3 25
$48.2B
$42.0B
Q2 25
$47.3B
$42.5B
Q1 25
$48.0B
$42.0B
Q4 24
$48.2B
$42.6B
Q3 24
$48.6B
$44.2B
Q2 24
$48.9B
$45.6B
Debt / Equity
ADI
ADI
EMR
EMR
Q1 26
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADI
ADI
EMR
EMR
Operating Cash FlowLast quarter
$1.4B
$699.0M
Free Cash FlowOCF − Capex
$1.3B
$602.0M
FCF MarginFCF / Revenue
39.8%
13.9%
Capex IntensityCapex / Revenue
3.5%
2.2%
Cash ConversionOCF / Net Profit
1.65×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.6B
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADI
ADI
EMR
EMR
Q1 26
$1.4B
Q4 25
$1.7B
$699.0M
Q3 25
$1.2B
$3.1B
Q2 25
$819.5M
$1.1B
Q1 25
$1.1B
$241.0M
Q4 24
$1.1B
$777.0M
Q3 24
$855.0M
$3.3B
Q2 24
$807.9M
$1.1B
Free Cash Flow
ADI
ADI
EMR
EMR
Q1 26
$1.3B
Q4 25
$1.5B
$602.0M
Q3 25
$1.1B
$2.7B
Q2 25
$729.2M
$977.0M
Q1 25
$977.8M
$154.0M
Q4 24
$885.4M
$694.0M
Q3 24
$701.1M
$2.9B
Q2 24
$619.7M
$998.0M
FCF Margin
ADI
ADI
EMR
EMR
Q1 26
39.8%
Q4 25
48.3%
13.9%
Q3 25
37.7%
54.9%
Q2 25
27.6%
21.5%
Q1 25
40.4%
3.5%
Q4 24
36.2%
16.6%
Q3 24
30.3%
63.1%
Q2 24
28.7%
22.8%
Capex Intensity
ADI
ADI
EMR
EMR
Q1 26
3.5%
Q4 25
7.0%
2.2%
Q3 25
2.7%
8.9%
Q2 25
3.4%
2.0%
Q1 25
6.1%
2.0%
Q4 24
6.8%
2.0%
Q3 24
6.7%
9.1%
Q2 24
8.7%
2.1%
Cash Conversion
ADI
ADI
EMR
EMR
Q1 26
1.65×
Q4 25
2.16×
1.16×
Q3 25
2.25×
4.86×
Q2 25
1.44×
1.83×
Q1 25
2.88×
0.50×
Q4 24
2.20×
1.33×
Q3 24
2.18×
3.35×
Q2 24
2.67×
3.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADI
ADI

Sales Channel Directly To Consumer$1.4B44%
Automotive$794.4M25%
Communications$476.8M15%
Consumer$399.8M13%
Other$71.3M2%
Sales Channel Other$40.8M1%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons